Colin-Pierre C, Untereiner V, Sockalingum GD, Ramont L, Brézillon S
Investigation of Glypican-4 and-6 by Infrared Spectral Imaging during the Hair Growth Cycle
International Journal of Molecular Sciences (IF = 5.6), 24(5), 4291, 2023

Lepage V, Gratiaux J, Azzouz B, Slimano F, Jouannaud C, Parent D
Successful desensitization of a patient with hypersensitivity to pertuzumab: a case report
European Journal of Oncology Pharmacy (IF = 0.44), 6(3), e00046, 2023

Slimano F, Tournamille JF, Bardin C, Madelaine I, Hulin C, Moreau P, Rioufol C
Access and safety of dexamethasone in multiple myeloma patients
Bulletin du cancer (IF = 1.2), 110(6), 731-733, 2023

Guedon M, Le Bozec A, Brugel M, Clarenne J, Carlier C, Perrier M, Laurent M, Hettler D, Mongaret C, Bouché O, Slimano F
Cannabidiol–drug interaction in cancer patients: A retrospective study in a real‐life setting
British Journal of Clinical Pharmacology (IF = 3.4), 89(7), 2322-2328, 2023

Claustre G, Boulanger C, Maloisel F, Etienne-Selloum N, Fornecker LM, Durot E, Slimano F, Graff V
Comparative analysis of rituximab or obinutuzumab combined with CHOP in first-line treatment of follicular lymphoma
Journal of Cancer Research and Clinical Oncology (IF = 3.6), 149(5), 1883-1893, 2023

Fawzi M, Oubella A, Bimoussa A, Saadi M, El Ammari L, Ketatni EM, Morjani H, Ait Itto MY, Auhmani A
Diastereomerically pure (S)‐verbenone‐isoxazoline hybrids: Synthesis, molecular structure, Hirshfeld surface analysis, density functional theory, cytotoxic effect, and apoptosis induction
Journal of Heterocyclic Chemistry (IF = 2.4), 60(2), 207-218, 2023

Ousidi ANA, Bimoussa A, Loubidi M, Fawzi M, Laamari Y, Oubella A, Maatallah M, Berteina-Raboin S, Auhmani A, Labd Taha M, Morjani H, Ait Itto MY
Design, Synthesis, Cytotoxic Effect Evaluation and Molecular Docking of (R)‐Camphor‐Based Thiazolidinone‐Isoxazole and Thiazolidinone‐1, 2, 3‐triazole Hybrids
ChemistrySelect (IF = 2.1), 8(1), e202203349, 2023

Fawzi M, Bimoussa A, Laamari Y, Oussidi ANA, Oubella A, Ketatni EM, Saadi M, El Ammari L, Morjani H, Ait Itto MY, Auhmani A
New (S)-verbenone-isoxazoline-1, 3, 4-thiadiazole hybrids: synthesis, anticancer activity and apoptosis-inducing effect
Future Medicinal Chemistry (IF = 4.2), 15(17), 1603-1619, 2023

Byadi S, Abdoullah B, Fawzi M, Irrou E, Ait Elmachkouri Y, Oubella A, Auhmani A, Morjani H, Labd Taha M, Robert A, Aboulmouhajir A, Ait Itto My
Discovery of a new Bcl-2 inhibitor through synthesis, anticancer activity, docking and MD simulations
Journal of Biomolecular Structure and Dynamics (IF = 4.4), 2023

Bimoussa A, Fawzi M, Oubella A, Ejaz SA, Sajjad Bilal M, Labd Taha M, Auhmani A, Morjani H, Robert A, Riahi A, Ait Itto MY
Hybrids of thiazolidinone with 1, 2, 3-triazole derivatives: design, synthesis, biological evaluation, in silico studies, molecular docking, molecular dynamics simulations, and ADMET profiling
Journal of Biomolecular Structure and Dynamics (IF = 4.4), 41(21), 11987-11999, 2023

Zaiou M, Morjani H
Molecular Links between Cancer and Metabolic Diseases: New Perspectives and Therapeutic Strategies for Cancer Prevention and Treatment by Targeting Nutritional Patterns and Metabolic Alterations
Cancers (IF = 5.2), 15(4), 1350, 2023

Oubella A, Taia A, Byadi S, Ait Lahcen M, Bimoussa A, Essaber M, Podlipnik C, Morjani H, Ait Itto MY, Aatif A
Chemical profiling, cytotoxic activities through apoptosis induction in human fibrosarcoma and carcinoma cells, and molecular docking of some 1, 2, 3-triazole-isoxazoline hybrids using the eugenol as a precursors
Journal of Biomolecular Structure and Dynamics (IF = 4.4), 41(7), 2759-2771, 2023

Florent L, Saby C, Slimano F, Morjani H
BRAF V600-Mutated Metastatic Melanoma and Targeted Therapy Resistance: An Update of the Current Knowledge
Cancers (IF = 5.2), 15(9), 2607, 2023

Oubella A, Bimoussa A, Byadi S, Laamari Y, Fawzi M, N’ait ousidi A, Oblak D, Auhmani A, Riahi A, Morjani H, Ait Itto MY
Cytotoxic and apoptotic effects of some (R)-carvone-isoxazoline derivatives on human fibrosarcoma and carcinoma cells: experimental evaluation for cytotoxicity, molecular docking and molecular dynamics studies
Journal of Biomolecular Structure and Dynamics (IF = 4.4), 41(5), 1930-1943, 2023

Guillard J, Untereiner V, Garnotel R, Boulagnon-Rombi C, Gobinet C, Proult I, Sockalingum GD, Thiéfin G
Longitudinal Study of Cirrhosis Development in STAM and carbon tetrachloride Mouse Models Using Fourier Transform Infrared Spectral Imaging
Laboratory Investigation (IF = 5), 103(10), 100231, 2023

Antunes D, Albisetti A, Fricain M, Cherqui A, Derruau S
Management of Permanent Teeth in Dentigerous Cysts in Children: A Case Report
Cureus (IF = 1.2), 15(8), e44062, 2023

Oudahmane I, Sarkees E, Taha F, Vanmansart J, Vuiblet V, Larre S, Piot O
To what extent does freezing impact the mid-infrared signature of urine? Case of patients attending urology department
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy (IF = 4.4), 123820, 2023

Ksovreli M, Kachlishvili T, Mtiulishvili T, Dzmanashvili G, Batsatsashvili T, Zurabiani K, TUghushi D, Kantaria T, Nadaraia L, Rusishvili L, Piot O, Terryn C, Tchelidze P, Katsarava R, Kulikova N
Leucine-Based Pseudo-Proteins (LPPs) as Promising Biomaterials: A Study of Cell-Supporting Properties
Polymers (IF = 5), 15(15), 3328, 2023

Brunel B, Prada P, Slimano F, Boulagnon-Rombi C, Bouché O, Piot O
Deep learning for the prediction of the chemotherapy response of metastatic colorectal cancer: comparing and combining H&E staining histopathology and infrared spectral histopathology
Analyst (IF = 4.2), 148(16), 3909-3917, 2023

Prada P, Brunel B, Moulin D, Rouillon L, Netter P, Loeuille D, Slimano F, Bouche O, Peyrin-Biroulet L, Jouzeau JY, Piot O
Identification of circulating biomarkers of Crohn's disease and spondyloarthritis using Fourier transform infrared spectroscopy
Journal of Biophotonics (IF = 2.8), 16(2), e202200200, 2023

Goffin N, Buache E, Charpentier C, Lehrter V, Morjani H, Gobinet C, Piot O
Trajectory Inference for Unraveling Dynamic Biological Processes from Raman Spectral Data
Analytical Chemistry (IF = 7.4), 95(9), 4395-4403, 2023

Auhmani A, Fawzi M, Oubella A, El Mansouri AE, Bimoussa A, Ketatni EM, Saadi M, El Ammari L, Ait Itto MY, Morjani H, Auhmani A
Novel hydrazono-2-iminothiazolidin-4-ones based on a monoterpenic skelton as potential antitumor agents: Synthesis, DFT studies, in vitro cytotoxicity, apoptosis inducing properties and molecular docking
Chemistry & Biodiversity (IF = 2.745), 19(7), e202100836, 2022

Oubella A, Byadi S, Bimoussa A, Fawzi M, Auhmani A, Podlipnik C, Morjani H, Riahi A, Robert A, Ait Itto MY
Novel isoxazoline‐linked 1, 3, 4‐thiadiazole hybrids as anticancer agents: Design, synthesis, biological evaluation, molecular docking, and molecular dynamics simulation
Archiv der Pharmazie (IF = 4.613), 355(9), 2200066, 2022

Hrimla M, Oubella A, Laamari MR, Bahsis L, Ghaleb A, Auhmani A, Morjani H, Juive M, Stiriba SE
Click synthesis, anticancer activity, and molecular docking investigation of some functional 1, 2, 3-triazole derivatives
Biointerface Research in Applied Chemistry (IF = 0.35), 12(6), 7633-7667, 2022

Bimoussa A, Oubella A, Bamou FZ, Khdar ZA, Fawzi M, Laamari Y, Ait Itto MY, Morjani H, Auhmani A
New 1, 3, 4-thiadiazoles derivatives: Synthesis, antiproliferative activity, molecular docking and molecular dynamics
Future Medicinal Chemistry (IF = 4.767), 14(12), 881-897, 2022

Hachim ME, Oubella A, Byadi S, Fawzi M, Laamari Y, Bahsis L, Aboulmouhajir A, Morjani H, Podlipnik C, Auhmani A, Ait Itto MY
Newly synthesized (R)-carvone-derived 1, 2, 3-triazoles: structural, mechanistic, cytotoxic and molecular docking studies
Journal of Biomolecular Structure and Dynamics (IF = 5.235), 40(16), 7205-7217, 2022

Toussaint K, Appert-Collin A, Morjani H, Albrecht C, Sartelet H, Romier-Crouzet B, Maurice P, Duca L, Blaise S, Bennasroune A
Neuraminidase-1: a sialidase involved in the development of cancers and metabolic diseases
Cancers (IF = 6.575), 14(19), 4868, 2022

Bimoussa A, Oubella A, El Mansouri AE, Fawzi M, Laamari Y, Auhmani A, Ait Itto MY, Morjani H, Auhmani A
Synthesis and biological evaluation of novel thiazole analogs with both anti‐proliferative and mechanistic analyses and molecular docking studies
ChemistrySelect (IF = 2.307), 7(11), e202104270, 2022

Fawzi M, Oubella A, Bimoussa A, Bamou FZ, Khdar ZA, Auhmani A, Riahi A, Robert A, Morjani H, Ait Itto MY
Design, synthesis, evaluation of new 3-acetylisoxazolines and their hybrid analogous as anticancer agents: In vitro and in silico analysis
Computational Biology and Chemistry (IF = 3.737), 98, 107666, 2022

Oubella A, Fawzi M, Bimoussa A, N’Ait Ousidi A, Auhmani A, Riahi A, Robert A, El Firdoussi L, Morjani H, Ait Itto MY
Convenient route to benzo [1, 2, 3] selenadiazole–isoxazole hybrids and evaluation of their in vitro cytotoxicity
Chemical Papers (IF = 2.146), 76(5), 2935-2946, 2022

Bimoussa A, Oubella A, Bjij I, Fawzi M, Laamari Y, Ait Itto MY, Auhmani A, Morjani H, Cherqaoui D, Auhmani A
Design, synthesis, biological and computational assessment of new thiazolidin‐4‐one derivatives as potential anticancer agents through the apoptosis pathway
ChemistrySelect (IF = 2.307), 7(21), e202200165, 2022

Oubella A, Bimoussa A, N’ait Oussidi A, Fawzi M, Auhmani A, Morjani H, Riahi A, Esseffar M, Parish C, Ait Itto MY
New 1, 2, 3-triazoles from (R)-carvone: Synthesis, DFT mechanistic study and in vitro cytotoxic evaluation
Molecules (IF = 4.927), 27(3), 769, 2022

Ben Arfi K, Schneider C, Bennasroune A, Bouland N, Wolak-Thierry A, Collin G, Le CC, Toussaint K, Hachet C, Lehrter V, Dedieu S, Bouché O, Morjani H, Boulagnon-Rombi C, Appert-Collin A
Discoidin domain receptor 1 expression in colon cancer: roles and prognosis impact
Cancers (IF = 6.575), 14(4), 928, 2022

Van Gulick L, Saby C, Jaisson S, Okwieka A, Gillery P, Dervin E, Morjani H, Beljebbar A
An integrated approach to investigate age-related modifications of morphological, mechanical and structural properties of type I collagen
Acta Biomaterialia (IF = 10.633), 137, 64-78, 2022

Dubus M, Scomazzon L, Ledouble C, Braux J, Beljebbar A, Van Gulick L, Baldit A, Gorin C, Alemm H, Bouland N, Britton M, Schiavi J, Vaughan TJ, Mauprivez C, Kerdjoudj H
Hybrid Mineral/Organic Material Induces Bone Bridging and Bone Volume Augmentation in Rat Calvarial Critical Size Defects
Cells (IF = 7.666), 11(18), 2865, 2022

Boutegrabet W, Piot O, Guenot D, Gobinet C
Unsupervised Feature Selection by a Genetic Algorithm for Mid-Infrared Spectral Data
Analytical Chemistry (IF = 8), 94(46), 16050-16059, 2022

Essendoubi M, Andre N, Granger B, Clave C, Manfait M, Thuillier I, Piot O, Ginestar J
New approach for hair keratin characterization: Use of the confocal Raman spectroscopy to assess the effect of thermal stress on human hair fibre
International Journal of Cosmetic Science (IF = 0.64), 44(5), 588-601, 2022

Mazza C, Gaydou V, Eymard JC, Birembaut P, Untereiner V, Côté JF, Brocheriou I, Coeffic D, Villena P, Larré S, Vuiblet V, Piot O
Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging
Cancers (IF = 6.575), 14(1), 21, 2022

Brunel B, Alsamad F, Piot O
Toward automated machine learning in vibrational spectroscopy: Use and settings of genetic algorithms for pre-processing and regression optimization
Chemometrics and Intelligent Laboratory Systems (IF = 3.491), 219, 104444, 2021

Derruau S, Bogard F, Exartier-Menard G, Mauprivez C, Polidori G
Medical infrared thermography in odontogenic facial cellulitis as a clinical decision support tool. A technical note
Diagnostics (IF = 0.97), 11(11), 2045, 2021

Delarue M, Derruau S, Troyon P, Bogard F, Polidori G, Mauprivez C
Medical infrared thermography in peri-operative management of peripheral ameloblastoma: A case report
Photodiagnosis and Photodynamic Therapy (IF = 3.631), 34, 102167, 2021

El Mansouri AE, Oubella A, Danoun K, Ahmad M, Neyts J, Jochmans D, Snoeck R, Andrei G, Morjani H, Zahouily M, Lazrek HB
Discovery of novel furo [2, 3‐d] pyrimidin‐2‐one–1, 3, 4‐oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis
Archiv der Pharmazie (IF = 3.751), 354(10), 2100146, 2021

Saby C, Maquoi E, Saltel F, Morjani H
Collagen and discoidin domain receptor 1 partnership: a multifaceted role in the regulation of breast carcinoma cell phenotype
Frontiers in Cell and Developmental Biology (IF = 6.684), 9, 808625, 2021

Dʼalmeida R, Barbe C, Untereiner V, Ramaholimihaso F, Renard P, Sockalingum GD, Garnotel R, Thiefin G
White bile in patients with malignant biliary obstruction is an independent factor of poor survival
Endoscopy International Open (IF = 0.52), 9(2), E203-E209, 2021

Nizet P, Untereiner V, Sockalingum GD, Proult I, Terryn C, Jeanne A, Nannan L, Boulagnon-Rombi C, Sellier C, Rivet R, Ramont L, Brézillon S
Assessment of Ovarian Tumor Growth in Wild-Type and Lumican-Deficient Mice: Insights Using Infrared Spectral Imaging, Histopathology, and Immunohistochemistry
Cancers (IF = 6.639), 13(23), 5950, 2021

Boutegrabet W, Guenot D, Bouché O, Boulagnon-Rombi C, Marchal Bressenot A, Piot O, Gobinet C
Automatic Identification of Paraffin Pixels on FTIR Images Acquired on FFPE Human Samples
Analytical Chemistry (IF = 6.986), 93(8), 3750-3761, 2021

Colin-Pierre C, Untereiner V, Sockalingum GD, Berthélémy N, Danoux L, Bardey V, Mine S, Jeanmaire C, Ramont L, Brézillon S
Hair Histology and Glycosaminoglycans Distribution Probed by Infrared Spectral Imaging: Focus on Heparan Sulfate Proteoglycan and Glypican-1 during Hair Growth Cycle
Biomolecules (IF = 4.879), 11(2), 192, 2021

Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S
COVID-19 and Dentistry in 72 Questions: An Overview of the Literature
Journal of Clinical Medicine (IF = 4.241), 10(4), 779, 2021

El Mansouri AE, Oubella A, Mehdi A, AitItto MY, Zahouily M, Morjani H, Lazrek HB
Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents
Bioorganic Chemistry (IF = 5.275), 108, 104558, 2021

Derruau S, Gobinet C, Untereiner V, Sockalingum GD, Nassif A, Viguier M, Piot O, Lorimier S
New insights into hidradenitis suppurativa diagnosis via salivary infrared biosignatures: A pilot study
Journal of Biophotonics (IF = 3.207), 14(3), e202000327, 2021

Alsamad F, Brunel B, Vuiblet V, Gillery P, Jaisson S, Piot O
In depth investigation of collagen non-enzymatic glycation by Raman spectroscopy
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy (IF = 4.098), 251, 119382, 2021

Girault A, Peretti M, Badaoui M, Hémon A, Morjani H, Ouadid-Ahidouch H
The N and C-termini of SPCA2 regulate differently Kv10.1 function: role in the collagen 1-induced breast cancer cell survival
American Journal of Cancer Research (IF = 6.166), 11(1), 251-263, 2021

Essendoubi M, Alsamad F, Noël P, Meunier M, Scandolera A, Sandré J, Manfait M, Gobinet C, Reynaud R, Piot O
Combining Raman imaging and MCR‐ALS analysis for monitoring retinol permeation in human skin
Skin Research and Technology (IF = 2.365), 2021

Rammal H, Al Assaad A, Dosio F, Stella B, Maksimenko A, Mura S, Van Gulick L, Callewaert M, Desmaële D, Couvreur P, Morjani H, Beljebbar A
Investigation of squalene-doxorubicin distribution and interactions within single cancer cell using Raman microspectroscopy
Nanomedicine: Nanotechnology, Biology and Medicine (IF = 6.458), 102404, 2021

Laamari Y, Oubella A, Bimoussa A, El Mansouri AE, Ketatni EM, Mentre O, Ait Itto MY, Morjani H, Khouili M, Auhmani A
Design, Hemiysnthesis, crystal structure and anticancer activity of 1, 2, 3-triazoles derivatives of totarol
Bioorganic Chemistry (IF = 5.275), 115, 105165, 2021

Hachim ME, Oubella A, Byadi S, Fawzi M, Laamari Y, Bahsis L, Aboulmouhajir A, Morjani H, Podlipnik C, Auhmani A, Ait Itto MY
Newly synthesized (R)-carvone-derived 1, 2, 3-triazoles: structural, mechanistic, cytotoxic and molecular docking studies
Journal of Biomolecular Structure and Dynamics (IF = 3.310), 1-14, 2021

Oubella A, El Mansouri AE, Fawzi M, Bimoussa A, Laamari Y, Auhmani A, Morjani H, Robert A, Riahi A, Ait Itto MY
Thiazolidinone-linked1, 2, 3-triazoles with monoterpenic skeleton as new potential anticancer agents: design, synthesis and molecular docking studies
Bioorganic Chemistry (IF = 5.275), 105184, 2021

El Mansouri AE, Oubella A, Dânoun K, Ahmad M, Neyts J, Jochmans D, Snoeck R, Andrei G, Morjani H, Zahouily M, Lazrek HB
Discovery of novel furo [2, 3‐d] pyrimidin‐2‐one–1, 3, 4‐oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis
Archiv der Pharmazie (IF = 3.751), e2100146, 2021

Hadami K, Saby C, Dakka N, Collin G, Attaleb M, Khyatti M, Filali-Maltouf A, Morjani H, El Mzibri M
Degradation of p53 by HPV16-E6 variants isolated from cervical cancer specimens of Moroccan women
Gene (IF = 3.688), 791, 145709, 2021

Bimoussa A, Oubella A, Hachim ME, Fawzi M, Ait Itto MY, Mentre O, Ketatni EM, Bahsis L, Morjani H, Auhmani A
New enaminone sesquiterpenic: TiCl4-catalyzed synthesis, spectral characterization, crystal structure, Hirshfeld surface analysis, DFT studies and cytotoxic activity
Journal of Molecular Structure (IF = 3.196), 1241, 130622, 2021

Bimoussa A, Oubella A, Laamari Y, Fawzi M, Hachim ME, Ait Itto MY, Morjani H, Ketatni EM, Mentre O, Auhmani A
Hybrid of the 1, 2, 3‐triazole nucleus and sesquiterpene skeleton as a potential antitumor agent: Hemisynthesis, Molecular structure, Hirshfeld surface analysis, DFT, in vitro cytotoxic and apoptotic effects
Journal of Heterocyclic Chemistry (IF = 2.193), 2021, accepté pour publication

Fornasaro S, Alsamad F, Baia M, Batista de Carvalho LAE, Beleites C, Byrne HJ, Chiadò A, Chis M, Chisanga M, Daniel A, Dybas J, Eppe G, Falgayrac G, Faulds K, Gebavi H, Giorgis F, Goodacre R, Graham D, La Manna P, Laing S, Litti L, Lyng FM, Malek K, Malherbe C, Marques MPM, Meneghetti M, Mitri E, Mohaček-Grošev V, Morasso C, Muhamadali H, Musto P, Novara C, Pannico M, Penel G, Piot O, Rindzevicius T, Rusu EA, Schmidt MS, Sergo V, Sockalingum G, Untereiner V, Vanna R, Wiercigroch E, Bonifacio A
Surface Enhanced Raman Spectroscopy for quantitative analysis: results of a large-scale European multi-instrument interlaboratory study
Analytical Chemistry (IF = 6.35), 92(5), 4053-4064, 2020

Alsamad F, Gobinet C, Vuiblet V, Jaisson S, Piot O
Towards normalization selection of Raman data in the context of protein glycation: application of validity indices to PCA processed spectra
Analyst (IF = 4.019), 145(8), 2945-2957, 2020

Azan A, Grognot M, García-Sánchez T, Descamps L, Untereiner V, Piot O, Gallot G, Lluis MM
Monitoring the molecular composition of live cells exposed to electric pulses via label-free optical methods
Scientific Reports (IF = 4.011), 10(1), 1-13, 2020

Féré M, Gobinet C, Liu LH, Beljebbar A, Untereiner V, Gheldof D, Chollat M, Klossa J, Chatelain B, Piot O
Implementation of a classification strategy of Raman data collected in different clinical conditions: application to the diagnosis of chronic lymphocytic leukemia
Analytical and Bioanalytical Chemistry (IF = 3.286), 412(4), 949-962, 2020

Özcan C, Lestriez P, Berry-Kromer V, Thiebaud F, Sockalingum GD, Untereiner V, Angiboust JF, Josset Y
Misinterpretation of ISO 4049 standard recommendations: Impact on Young's modulus and conversion degree of dental composites
Journal of the Mechanical Behavior of Biomedical Materials (IF = 3.372), 110, 103947, 2020

Slimano F, Djerada Z, Guerin J, Bellouch MI, Brassart-Pasco S, Dukic S
Intratumoral distribution of YSNSG cyclopeptide in a mouse melanoma model using microdialysis
European Journal of Pharmaceutical Sciences (IF = 3.532), 143, 105201, 2020

Untereiner V, Garnotel R, Thiéfin G, Sockalingum GD
Interference of hemolysis, hyperlipidemia, and icterus on plasma infrared spectral profile
Analytical and Bioanalytical Chemistry (IF = 3.286), 412(4), 805-810, 2020

Jaisson S, Desmons A, Braconnier A, Wynckel A, Rieu P, Gillery P, Garnotel R
An unusually high plasma concentration of homocysteine resulting from a combination of so-called “secondary” etiologies
Clinical Biochemistry (IF = 2.43), 80, 52-55, 2020

Le CC, Bennasroune A, Collin G, Hachet C, Lehrter V, Rioult D, Dedieu S, Morjani H, Appert-Collin A
LRP-1 promotes colon cancer cell proliferation in 3D collagen matrices by mediating DDR1 endocytosis
Frontiers in Cell and Developmental Biology (IF = 5.206), 8, 412, 2020

Le CC, Bennasroune A, Langlois B, Salesse S, Boulagnon-Rombi C, Morjani H, Dedieu S, Appert-Collin A
Functional interplay between collagen network and cell behavior within tumor microenvironment in colorectal cancer
Frontiers in Oncology (IF = 4.137), 10, 527, 2020

El Bourakadi K, El Mehdi Mekhzoum M, Saby C, Morjani H, Chakchak H, Merghoub N, El Kacem Qaiss A, Bouhfid R
Synthesis, characterization and in-vitro anticancer activity of thiabendazole derived 1, 2, 3-triazoles derivatives
New Journal of Chemistry (IF = 3.069), 44(28), 12099-12106, 2020

Taia A, Essaber M, Oubella A, Aatif A, Bodiguel J, Jamart-Grégoire B, Ait Ito MY, Morjani H
Synthesis, characterization, and biological evaluation of new heterocyclic systems 1, 2, 3-triazole-isoxazoline from eugenol by the mixed condensation reactions
Synthetic Communications (IF = 1.439), 50(13), 2052-2065, 2020

Oubella A, Fawzi M, Auhmani A, Riahi A, Morjani H, Robert A, Ait Itto MY
Synthesis and Antitumor Activity of Novel Heterocyclic Systems with Monoterpenic Skeleton Combining Dichlorocyclopropane and 1, 3, 4-Thiadiazole Nucleus
ChemistrySelect (IF = 1.716), 5(21), 6403-6406, 2020

Chan KLA, Altharawi A, Fale P, Song CL, Kazarian SG, Cinque G, Untereiner V, Sockalingum GD
Transmission Fourier transform infrared spectroscopic imaging, mapping, and synchrotron scanning microscopy with zinc sulfide hemispheres on living mammalian cells at sub-cellular resolution
Applied Spectroscopy (IF = 2.064), 74(5), 544-552, 2020

Brézillon S, Untereiner V, Mohamed HT, Ahallal E, Proult I, Nizet P, Boulagnon-Rombi C, Sockalingum GD
Label-Free Infrared Spectral Histology of Skin Tissue Part II: Impact of a Lumican-Derived Peptide on Melanoma Growth
Frontiers in Cell and Developmental Biology (IF = 5.201), 8, 377, 2020

Nannan L, Untereiner V, Proult I, Boulagnon-Rombi C, Colin-Pierre C, Sockalingum GD, Brézillon S
Label-Free Infrared Spectral Histology of Skin Tissue Part I: Impact of Lumican on Extracellular Matrix Integrity
Frontiers in Cell and Developmental Biology (IF = 5.201), 8, 320, 2020

Medipally DK, Cullen D, Untereiner V, Bryant J, Sockalingum GD, Nguyen TNQ, Noone E, Bradshaw S, Finn M, Dunne M, Shannon AM, Armstrong J, Meade AD, Lyng FM
Effect of hemolysis on Fourier transform infrared and Raman spectra of blood plasma
Journal of Biophotonics (IF = 3.763), e201960173, 2020

Guo S, Beleites C, Neugebauer U, Abalde-Cela S, Afseth NK, Alsamad F, Anand S, Araujo-Andrade C, Aškrabić S, Avci E, Baia M, Baranska M, Baria E, Batista de Carvalho LAE, de Bettignies P, Bonifacio A, Bonnier F, Brauchle EM, Byrne HJ, Chourpa I, Cicchi R, Cuisinier F, Culha M, Dahms M, David C, Duponchel L, Duraipandian S, El-Mashtoly SF, Ellis DI, Eppe G, Falgayrac G, Gamulin O, Gardner B, Gardner P, Gerwert K, Giamarellos-Bourboulis EJ, Gizurarson S, Gnyba M, Goodacre R, Grysan P, Guntinas-Lichius O, Helgadottir H, Grošev VM, Kendall C, Kiselev R, Kölbach M, Krafft C, Krishnamoorthy S, Kubryck P, Lendl B, Loza-Alvarez P, Lyng FM, Machill S, Malherbe C, Marro M, Marques MPM, Matuszyk E, Morasso CF, Moreau M, Muhamadali H, Mussi V, Notingher I, Pacia MZ, Pavone FS, Penel G, Petersen D, Piot O, Rau JV, Richter M, Rybarczyk MK, Salehi H, Schenke-Layland K, Schlücker S, Schosserer M, Schütze K, Sergo V, Sinjab F, Smulko J, Sockalingum GD, Stiebing C, Stone N, Untereiner V, Vanna R, Wieland K, Popp J, Bocklitz T
Comparability of Raman spectroscopic configurations: a large scale cross-laboratory study
Analytical Chemistry(IF = 6.785), 92(24), 15745-15756, 2020

Derruau S, Robinet J, Untereiner V, Piot O, Sockalingum GD, Lorimier S
Vibrational spectroscopy saliva profiling as biometric tool for disease diagnostics: A systematic literature review
Molecules(IF = 3.267), 25(18), 4142, 2020

Braux J, Jourdain ML, Guillaume C, Untereiner V, Piot O, Baehr A, Klymiuk N, Winter N, Berri M, Buzoni-Gatel D, Caballero I, Guillon A, Si-Tahar M, Jacquot J, Velard F
CFTR-deficient pigs display alterations of bone microarchitecture and composition at birth
Journal of Cystic Fibrosis(IF = 4.759), 19(3), 466-475, 2020

Sarazin T , Collin G, Buache E, Van Gulick L, Charpentier C, Terryn C, Morjani H, Saby C
Type I Collagen Aging Increases Expression and Activation of EGFR and Induces Resistance to Erlotinib in Lung Carcinoma in 3D Matrix Model
Frontiers in Oncology(IF = 4.848), 10, 1593, 2020

Courageot MP, Duca L, Martiny L, Devarenne-Charpentier E, Morjani H, El Btaouri H
Thrombospondin-1 Receptor CD47 Overexpression Contributes to P-Glycoprotein-Mediated Multidrug Resistance Against Doxorubicin in Thyroid Carcinoma FTC-133 Cells
Frontiers in Oncology(IF = 4.848), 10, 2688, 2020

Slimano F, Djerada Z, Guerin J, Bellouch MI, Brassart-Pasco S, Dukic S
Intratumoral distribution of YSNSG cyclopeptide in a mouse melanoma model using microdialysis
European Journal of Pharmaceutical Sciences(IF = 3.616), 143, 105201, 2020

Moreau J, Bouzy P, Guillard J, Untereiner V, Garnotel R, Marchal A, Gobinet C, Terryn C, Sockalingum GD, Thiéfin G
Analysis of Hepatic Fibrosis Characteristics in Cirrhotic Patients with and without Hepatocellular Carcinoma by FTIR Spectral Imaging
Molecules(IF = 3.267), 25(18), 4092, 2020

El Mansouri AE, Oubella A, Maatallah M, AitItto MY, Zahouily M, Morjani H, Lazrek HB
Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1, 2, 4-oxadiazole hybrids as potential anticancer agents
Bioorganic & Medicinal Chemistry Letters(IF = 2.572), 30(19), 127438, 2020

Kumar AV, Brézillon S, Untereiner V, Sockalingum GD, Katakam SK, Mohamed HT, Kemper B, Greve B, Mohr B, Ibrahim SA, Goycoolea FM, Kiesel L, Pavao MSG, Motta JM, Götte M
HS2ST1‐dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior
Cancer Science(IF = 4.966), 111(8), 2907, 2020

Medipally DK, Cullen D, Untereiner V, Sockalingum GD, Maguire A, Nguyen TNQ, Bryant J, Noone E, Bradshaw S, Finn M, Dunne M, Shannon AM, Armstrong J, Meade AD, Lyng FM
Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis
Therapeutic advances in medical oncology(IF = 6.852), 12, 1758835920918499, 2020

Mohamed HT, Untereiner V, Cinque G, Ibrahim SA, Götte M, Nguyen NQ, Rivet R, Sockalingum GD, Brézillon S
Infrared microspectroscopy and imaging analysis of inflammatory and non-inflammatory breast cancer cells and their GAG secretome
Molecules(IF = 3.267), 25(18), 4300, 2020

Al-Rifai R, Tournois C, Kheirallah S, Bouland N, Poitevin G, Nguyen P, Beljebbar A
Subcutaneous and transcutaneous monitoring of murine hindlimb ischemia by in vivo Raman spectroscopy
Analyst (IF = 4.019), 144(15), 4677-4686, 2019

Gaydou V, Polette M, Gobinet C, Kileztky C, Angiboust JF, Birembaut P, Vuiblet V, Piot O
New insights into spectral histopathology: infrared-based scoring of tumour aggressiveness of squamous cell lung carcinomas
Chemical Science (IF = 9.063), 10(15), 4246-4258, 2019

Van Gulick L, Saby C, Morjani H, Beljebbar A
Age-related changes in molecular organization of type I collagen in tendon as probed by polarized SHG and Raman microspectroscopy
Scientific Reports (IF = 4.122), 9(1), 7280, 2019

Féré M, Piot O, Liu LH, Beljebbar A, Untereiner V, Gheldof D, Chollat M, Klossa J, Chatelain B, Gobinet C
Focus on pre-processing step to ensure the clinical transferability of Raman data acquired on lymphocytes in different experimental and instrumental conditions
Vibrational Spectroscopy (IF = 1.363), 103, 102931, 2019

Saby C, Collin G, Sinane M, Buache E, Van Gulick L, Saltel F, Maquoi E, Morjani H
DDR1 and MT1-MMP Expression Levels Are Determinant for Triggering BIK-Mediated Apoptosis by 3D Type I Collagen Matrix in Invasive Basal-Like Breast Carcinoma Cells
Frontiers in Pharmacology (IF = 3.831), 10, 462, 2019

Derruau S, Gobinet C, Mateu A, Untereiner V, Lorimier S, Piot O
Shedding light on confounding factors likely to affect salivary infrared biosignatures
Analytical and Bioanalytical Chemistry (IF = 3.307), 411(11), 2283-2290, 2019

Essendoubi M, Meunier M, Scandolera A, Gobinet C, Manfait M, Lambert C, Auriol D, Reynaud R, Piot O
Conformation changes in human hair keratin observed using confocal Raman spectroscopy after active ingredient application
International Journal of Cosmetic Science (IF = 1.777), 2019

Gonchar A, Jouet D, Skírnisson K, Krupenko D, Galaktionov KV
Transatlantic discovery of Notocotylus atlanticus (Digenea: Notocotylidae) based on life cycle data
Parasitology Research (IF = 2.558), 118(5), 1445-1456, 2019

Peretti M, Badaoui M, Girault A, Van Gulick L, Mabille MP, Tebbakha R, Sevestre H, Morjani H, Ouadid-Ahidouch H
Original association of ion transporters mediates the ECM-induced breast cancer cell survival: Kv10.1-Orai1-SPCA2 partnership
Scientific Reports (IF = 4.122), 9(1), 1175, 2019

Szafraniec E, Kus E, Wislocka A, Kukla B, Sierka E, Untereiner V, Sockalingum GD, Chlopicki S, Baranska M
Raman spectroscopy-based insight into lipid droplets presence and contents in liver sinusoidal endothelial cells and hepatocytes
Journal of Biophotonics (IF = 3.768), 12(4), e201800290, 2019

Bœuf-Muraille G, Rigaux G, Callewaert M, Zambrano N, Van Gulick L, Roullin VG, Terryn C, Andry M-C, Chuburu F, Dukic S, Molinari M
Evaluation of mTHPC-loaded PLGA nanoparticles for in vitro photodynamic therapy on C6 glioma cell line
Photodiagnosis and Photodynamic Therapy (IF = 2.895), 25, 448-455, 2019

Desmons A, Okwieka A, Doué M, Gorisse L, Vuiblet V, Pietrement C, Gillery P, Jaisson S
Proteasome-dependent degradation of intracellular carbamylated proteins
Aging (IF = 5.179), 2019

Collin G, Huna A, Warnier M, Flaman JM, Bernard D
Transcriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence
Cell Death & Disease (IF = 5.959), 9(3), 259, 2018

Da Silva J, Lameiras P, Beljebbar A, Berquand A, Villemin M, Ramont L, Dukic S, Nuzillard JM, Molinari M, Gautier M, Brassart-Pasco S, Brassart B
Structural characterization and in vivo pro-tumor properties of a highly conserved matrikine
Oncotarget (IF = 5.168), 9(25), 17839-17857, 2018

Saby C, Rammal H, Magnien K, Buache E, Brassart-Pasco S, Van-Gulick L, Jeannesson P, Maquoi E, Morjani H
Age-related modifications of type I collagen impair DDR1-induced apoptosis in non-invasive breast carcinoma cells
Cell Adhesion & Migration (IF = 3.566), 12(4), 335-347, 2018

Lambert E, Fuselier E, Ramont L, Brassart B, Dukic S, Oudart JB, Dupont-Deshorgue A, Sellier C, Machado C, Dauchez M, Monboisse JC, Maquart FX, Baud S, Brassart-Pasco S
Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition
Scientific Reports (IF = 4.122), 8(1), 9837, 2018

Romier B, Ivaldi C, Sartelet H, Heinz A, Schmelzer CEH, Garnotel R, Guillot A, Jonquet J, Bertin E, Guéant JL, Alberto JM, Bronowicki JP, Amoyel J, Hocine T, Duca L, Maurice P, Bennasroune A, Martiny L, Debelle L, Durlach V, Blaise S
Production of Elastin-Derived Peptides Contributes to the Development of Nonalcoholic Steatohepatitis
Diabetes (IF = 7.273), 67(8), 1604-1615, 2018

Yuan R, Rao T, Cheng F, Yu WM, Ruan Y, Zhang XB, Larré S
Quantum dot-based fluorescent probes for targeted imaging of the EJ human bladder urothelial cancer cell line
Experimental and Therapeutic Medicine (IF = 1.410), 16(6), 4779-4783, 2018

Lehbili M, Alabdul Magid A, Kabouche A, Voutquenne-Nazabadioko L, Morjani H, Harakat D, Kabouche Z
Triterpenoid saponins from Scabiosa stellata collected in North-eastern Algeria
Phytochemistry (IF = 3.186), 150, 40-49, 2018

Sebiskveradze D, Bertino B, Gaydou V, Dugaret AS, Roquet M, Zugaj DE, Voegel JJ, Jeannesson P, Manfait M, Piot O
Mid-infrared spectral microimaging of inflammatory skin lesions
Journal of Biophotonics (IF = 3.768), 11(7), e201700380, 2018

Mohamed HT, Untereiner V, Proult I, Ibrahim SA, Götte M, El-Shinawi M, Mohamed MM, Sockalingum GD, Brézillon S
Characterization of inflammatory breast cancer: a vibrational microspectroscopy and imaging approach at the cellular and tissue level
Analyst (IF = 3.864), 143(24), 6103-6112, 2018

Migault C, Lebrun D, Toubas O, Nguyen Y, Giltat A, Julien G, Toubas D, Lebargy F, Delmer A, Bani-Sadr F
Pulmonary adverse events related to idelalisib therapy: A single centre experience
Journal of Chemotherapy (IF = 1.490), 30(5), 318-322, 2018

Badaoui M, Mimsy-Julienne C, Saby C, Van Gulick L, Peretti M, Jeannesson P, Morjani H, Ouadid-Ahidouch H
Collagen type 1 promotes survival of human breast cancer cells by overexpressing Kv10.1 potassium and Orai1 calcium channels through DDR1-dependent pathway
Oncotarget (IF = 5.168), 9(37), 24653-24671, 2018

Assenat E, Pageaux GP, Thézenas S, Peron JM, Bécouarn Y, Seitz JF, Merle P, Blanc JF, Bouché O, Ramdani M, Poujol S, de Forges H, Ychou M, Boige V
Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial
British Journal of Cancer (IF = 5.922), 120, 896–902, 2019

Bidard FC, Kiavue N, Ychou M, Cabel L, Stern MH, Madic J, Saliou A, Rampanou A, Decraene C, Bouché O, Rivoire M, Ghiringhelli F, Francois E, Guimbaud R, Mineur L, Khemissa-Akouz F, Mazard T, Moussata D, Proudhon C, Pierga JY, Stanbury T, Thézenas S, Mariani P
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
Cells (IF = 4.829), 8(6), 516, 2019

Lacas B, Bouché O, Etienne PL, Gasmi M, Texereau P, Gargot D, Lombard-Bohas C, Azzedine A, Denis B, Geoffroy P, Auby D, Michel P, Pignon JP, Lepage C, Ducreux M, Borget I
Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial
Expert Review of Pharmacoeconomics & Outcomes Research (IF = 1.797), 2019

Jouve JL, Lecomte T, Bouché O, Barbier E, Akouz FK, Riachi G, Khac EN, Ollivier-Hourmand I, Debette-Gratien M, Faroux R, Villing AL, Vergniol J, Ramee JF, Bronowicki JP, Seitz JF, Legoux JL, Denis J, Manfredi S, Phelip JM; PRODIGE-11 investigators/collaborators
Pravastatin combination with Sorafenib does not improve survival in advanced hepatocellular carcinoma
Journal of Hepatology (IF = 14.911), 2019

Malka D, François E, Penault-Llorca F, Castan F, Bouché O, Bennouna J, Ghiringhelli F, de la Fouchardière C, Borg C, Samalin E, Bachet JB, Raoul JL, Miglianico L, Bengrine-Lefèvre L, Dahan L, Lecaille C, Aparicio T, Stanbury T, Perrier H, Cayre A, Laurent-Puig P, Gourgou S, Emile JF, Taïeb J
FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial
European Journal of Cancer (IF = 7.191), 115, 97-106, 2019

Bennouna J, André T, Campion L, Hiret S, Miglianico L, Mineur L, Touchefeu Y, Artru P, Asmis T, Bouché O, Borde F, Kavan P, Lam YH, Rajpar LS, Emile JF, Jouffroy C, Gill S, Taïeb J
Rationale and design of the IROCAS study: multicenter, international, randomized phase 3 trial comparing adjuvant modified (m) FOLFIRINOX to mFOLFOX6 in patients with high-risk stage III (pT4 and/or N2) colon cancer—A UNICANCER GI-PRODIGE Trial
Clinical Colorectal Cancer (IF = 3.961), 18(1), e69-e73, 2019

Toulmonde M, Blay JY, Bouché O, Mir O, Penel N, Isambert N, Duffaud F, Bompas E, Esnaud T, Boidot R, Geneste D, Ghiringhelli F, Lucchesi C, Bellera CA, Le Loarer F, Italiano A
Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study
Clinical Cancer Research (IF = 10.199), 2019

Basse C, Italiano A, Penel N, Mir O, Chemin C, Toulmonde M, Duffaud F, Le Cesne A, Chevreau C, Maynou C, Anract P, Gouin F, Rios M, Firmin N, Kurtz JE, Kerbrat P, Piperno-Neumann S, Bertucci F, Rosset P, Isambert N, Bompas E, Dubray-Longeras P, Fiorenza F, Le Maignan C, Chaigneau L, Thyss A, Bouché O, Eymard JC, Delcambre Lair C, Adam J, Karanian M, Lebbé C, Dupré A, Meeus P, Brahmi M, Dufresne A, Ducimetière F, Ray-Coquard I, Blay JY
Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years
International Journal of Cancer (IF = 7.360), 2019

Dohan A, Gallix B, Guiu B, Le Malicot K, Reinhold C, Soyer P, Bennouna J, Ghiringhelli F, Barbier E, Boige V, Taieb J, Bouché O, François E, Phelip JM, Borel C, Faroux R, Seitz JF, Jacquot S, Ben Abdelghani M, Khemissa-Akouz F, Genet D, Jouve JL, Rinaldi Y, Desseigne F, Texereau P, Suc E, Lepage C, Aparico T, Hoeffel C
Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab
Gut (IF = 17.016), 2019

Moreau J, Ordan MA, Barbe C, Mazza C, Perrier M, Botsen D, Brasseur M, Portefaix C, Renard Y, Tallière B, Bertin E, Hoeffel C, Bouché O
Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy
Cancer Medicine (IF = 3.202), 2019

Botsen D, Lepoix E, Mazza C, Brasseur M, Grange A, Slimano F, Bouché O
Oxaliplatin-desensitization procedure is safe and feasible in an outpatient cancer unit in France
Supportive Care in Cancer (IF = 2.676), 2019

Rompteaux P, Gagnière J, Gornet JM, Coriat R, Baumgaertner I, Lecomte T, Afchain P, Zaanan A, Pocard M, Bachet JB, Bonichon-Lamichhane N, Bouché O, Faucheron JL, Forestier J, Lecaille C, Manfredi S, Tougeron D, Terrebonne E, Chehimi M, Villing AL, Sarda C, Legoux JL, Benamouzig R, Aparicio T
Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study
European Journal of Surgical Oncology (IF = 3.688), 45(3), 331-335, 2019

Narjoux G, Clarenne J, Azzouz B, Zeller PS, Slimano F, Bouché O
Nightmares and hallucinations with aprepitant and opium powder: a suspected drug-drug interaction
British Journal of Clinical Pharmacology (IF = 3.838), 85(2), 454-456, 2019

Bennouna J, Hiret S, Bertaut A, Bouché O, Deplanque G, Borel C, François E, Conroy T, Ghiringhelli F, des Guetz G, Seitz JF, Artru P, Hebbar M, Stanbury T, Denis MG, Adenis A, Borg C
Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial
JAMA Oncology (IF = 20.871), 5(1), 83-90, 2019

Touchefeu Y, Guimbaud R, Louvet C, Dahan L, Samalin E, Barbier E, Le Malicot K, Cohen R, Gornet JM, Aparicio T, Nguyen S, Azzedine A, Etienne PL, Phelip JM, Hammel P, Chapelle N, Sefrioui D, Mineur L, Lepage C, Bouche O
Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial
Gastric Cancer (IF = 5.045), 2019

Biran V, Decobert F, Bednarek N, Boizeau P, Benoist JF, Claustrat B, Barré J, Colella M, Frérot A, Garnotel R, Graesslin O, Haddad B, Launay JM, Schmitz T, Schroedt J, Virlouvet AL, Guilmin-Crépon S, Yacoubi A, Jacqz-Aigrain E, Gressens P, Alberti C, Baud O
Melatonin Levels in Preterm and Term Infants and Their Mothers
International Journal of Molecular Sciences (IF = 3.687), 20(9), 2019

Tutolo M, Cornu JN, Bauer RM, Ahyai S, Bozzini G, Heesakkers J, Drake MJ, Tikkinen KAO, Launonen E, Larré S, Thiruchelvam N, Lee R, Li P, Favro M, Zaffuto E, Bachmann A, Martinez-Salamanca JI, Pichon T, De Nunzio C, Ammirati E, Haab F, Van Der Aa F
Efficacy and safety of artificial urinary sphincter (AUS): Results of a large multi-institutional cohort of patients with mid-term follow-up
Neurourology and Urodynamics (IF = 3.263), 38(2), 710-718, 2019

Lin F, Yu W, Rao T, Ning J, Ruan Y, Xia Y, Ye P, Lu J, Cheng F, Larré S
The Anatomic Structure of a Fused Renal Pyramid and Its Clinical Significance in the Establishment of Percutaneous Renal Access
Urology (IF = 2.300), 124, 38-45, 2019

Fontenil A, Bigot P, Bernhard JC, Beauval JB, Soulié M, Charles T, Larré S, Salomon L, Azzouzi R, Méjean A, Bensalah K
Who is dying after nephrectomy for cancer? Study of risk factors and causes of death after analyzing morbidity and mortality reviews (UroCCR-33 study)
Progrès en Urologie (IF = 0.819), 29(5), 282-287, 2019

Ben Arfi K, Marchal A, Hafian H, Boulagnon-Rombi C
Carcinoma cuniculatum: An unusual oral tumor
Annales de Pathologie (IF = 0.373), 2019

Durot C, Mulé S, Soyer P, Marchal A, Grange F, Hoeffel C
Metastatic melanoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with pembrolizumab
European Radiology (IF = 4.027), 29(6), 3183-3191, 2019

Jairath V, Peyrin-Biroulet L, Zou G, Mosli M, Vande Casteele N, Pai RK, Valasek MA, Marchal-Bressenot A, Stitt LW, Shackelton LM, Khanna R, D'Haens GR, Sandborn WJ, Olson A, Feagan BG, Pai RK
Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial
Gut (IF = 17.016), 68(7), 1162-1168, 2019

Rizk M, Guilloteau A, Mouillot T, Thiefin G, Bronowicki JP, Richou C, Doffoel M, Diab Assaf M, Hillon P, Cottet V
Dietary components modulate the risk of hepatocellular carcinoma in cirrhotic patients
Nutrition Research (IF = 2.707), 61, 82-94, 2019

Faivre M, Cottet V, Bour JB, Richou C, Valmary-Degano S, Thiefin G, Andreoletti L, Geist C, Schvoerer E, Malvé B, Habersetzer F, Fafi-Kremer S, Binquet C, Jouve JL, Bronowicki JP, Doffoel M, Hillon P, Herbein G, Monnet E, Di Martino V; CirCE Study Group
Impact of Cytomegalovirus Infection on the Outcome of Patients With Cirrhosis: A Preliminary Study
Journal of Clinical Gastroenterology (IF = 2.968), 53(3), 236-241, 2019

Brenet Defour L, Mulé S, Tenenhaus A, Piardi T, Sommacale D, Hoeffel C, Thiéfin G
Hepatocellular carcinoma: CT texture analysis as a predictor of survival after surgical resection
European Radiology (IF = 4.027), 29(3), 1231-1239, 2019

Weil D, Heurgue-Berlot A, Monnet E, Chassagne S, Cervoni JP, Feron T, Grandvallet C, Muel E, Bronowicki JP, Thiefin G, Di Martino V, Bardonnet K, Thévenot T
Accuracy of calprotectin using the Quantum Blue Reader for the diagnosis of spontaneous bacterial peritonitis in liver cirrhosis
Hepatology Research (IF = 3.415), 49(1), 72-81, 2019

Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A, Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL
Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression
Kidney International (IF = 8.429), 95(6), 1471-1485, 2019

Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Van Huyen JPD, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D
Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens
Journal of the American Society of Nephrology (IF = 8.655), 30(4), 692-709, 2019

Botsen D, Ordan MA, Barbe C, Mazza C, Perrier M, Moreau J, Brasseur M, Renard Y, Taillière B, Slimano F, Bertin E, Bouché O
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients
BMC Cancer (IF = 3.288), 18(1), 955, 2018

Bouché O, Cesne AL, Rios M, Chaigneau L, Italiano A, Duffaud F, Lecomte T, Arsène D, Manfredi S, Aparicio T, Remy S, Isambert N, Collard O, Priou F, Bertucci F, Sambuc R, Bisot-Locard S, Bourges O, Chabaud S, Blay JY
EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib
PLoS One (IF = 2.766), 13(9), e0204117, 2018

Neuzillet C, Gaujoux S, Williet N, Bachet JB, Bauguion L, Colson Durand L, Conroy T, Dahan L, Gilabert M, Huguet F, Marthey L, Meilleroux J, de Mestier L, Napoléon B, Portales F, Sa Cunha A, Schwarz L, Taieb J, Chibaudel B, Bouché O, Hammel P
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)
Digestive and Liver Disease (IF = 3.287), 50(12), 1257-1271, 2018

Kim S, François E, André T, Samalin E, Jary M, El Hajbi F, Baba-Hamed N, Pernot S, Kaminsky MC, Bouché O, Desrame J, Zoubir M, Ghiringhelli F, Parzy A, De La Fouchardiere C, Smith D, Deberne M, Spehner L, Badet N, Adotevi O, Anota A, Meurisse A, Vernerey D, Taieb J, Vendrely V, Buecher B, Borg C
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study
Lancet Oncology (IF = 36.418), 19(8), 1094-1106, 2018

Zaanan A, Bouché O, Benhaim L, Buecher B, Chapelle N, Dubreuil O, Fares N, Granger V, Lefort C, Gagniere J, Meilleroux J, Baumann AS, Vendrely V, Ducreux M, Michel P
Gastric cancer: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)
Digestive and Liver Disease (IF = 3.287), 50(8), 768-779, 2018

Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials
European Journal of Cancer (IF = 7.191), 98, 1-9, 2018

André T, Vernerey D, Mineur L, Bennouna J, Desrame J, Faroux R, Fratte S, Hug de Larauze M, Paget-Bailly S, Chibaudel B, Bez J, Dauba J, Louvet C, Lepere C, Dupuis O, Becouarn Y, Mabro M, Egreteau J, Bouche O, Deplanque G, Ychou M, Galais MP, Ghiringhelli F, Dourthe LM, Bachet JB, Khalil A, Bonnetain F, de Gramont A, Taieb J
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial
Journal of Clinical Oncology (IF = 26.303), 36(15), 1469-1477, 2018

Texier M, Rotolo F, Ducreux M, Bouché O, Pignon JP, Michiels S
Evaluation of Treatment Effect with Paired Failure Times in a Single-Arm Phase II Trial in Oncology
Computational and Mathematical Methods in Medicine (IF = 1.545), 2018, 1672176, 2018

Boulagnon-Rombi C, Schneider C, Leandri C, Jeanne A, Grybek V, Bressenot AM, Barbe C, Marquet B, Nasri S, Coquelet C, Fichel C, Bouland N, Bonnomet A, Kianmanesh R, Lebre AS, Bouché O, Diebold MD, Bellon G, Dedieu S
LRP1 expression in colon cancer predicts clinical outcome
Oncotarget (IF = 5.168), 9(10), 8849-8869, 2018

Crespel C, Brami C, de Boissieu P, Mazza C, Chauvet K, Lemoine A, Gavlak B, Léandri C, Brasseur M, Bertin E, Bouché O
Evaluation of the feasibility of a program of adapted physical activity in day hospital of digestive oncology: From the point of view of patients
Bulletin du Cancer (IF = 0.840), 105(3), 228-233, 2018

Zaanan A, Samalin E, Aparicio T, Bouche O, Laurent-Puig P, Manfredi S, Michel P, Monterymard C, Moreau M, Rougier P, Tougeron D, Taieb J, Louvet C
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)
Digestive and Liver Disease (IF = 3.287), 50(4), 408-410, 2018

Aparicio T, Ghiringhelli F, Boige V, Le Malicot K, Taieb J, Bouché O, Phelip JM, François E, Borel C, Faroux R, Dahan L, Jacquot S, Genet D, Khemissa F, Suc E, Desseigne F, Texereau P, Lepage C, Bennouna J
Bevacizumab Maintenance Versus No Maintenance During Chemotherapy-Free Intervals in Metastatic Colorectal Cancer: A Randomized Phase III Trial (PRODIGE 9)
Journal of Clinical Oncology (IF = 26.303), 36(7), 674-681, 2018

Matysiak-Budnik T, Fabiani B, Hennequin C, Thieblemont C, Malamut G, Cadiot G, Bouché O, Ruskoné-Fourmestraux A
Gastrointestinal lymphomas: French Intergroup clinical practice recommendations for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFH)
Digestive and Liver Disease (IF = 3.287), 50(2), 124-131, 2018

Ordan MA, Mazza C, Barbe C, Perrier M, Botsen D, Renard Y, Moreau J, Brasseur M, Taillière B, Bertin É, Bouché O
Feasibility of systematic handgrip strength testing in digestive cancer patients treated with chemotherapy: The FIGHTDIGO study
Cancer (IF = 6.537), 124(7), 1501-1506, 2018

Tranquart F, Dujardin PA, Bouché O, Marcus C, Borg C, Manzoni P, Douillard JY, Labbe-Devilliers C, Terrebonne E, Smith D, Trillaud H, Capitain O, Aubé C, Spano JP, Lucidarme O, Ferru A, Tasu JP, Manfredi S, Bleuzen A, Léger J, Lecomte T
Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases
Ultraschall in der Medizin (IF = 4.389), 39(5), 544-558, 2018

Locher C, Batumona B, Afchain P, Carrère N, Samalin E, Cellier C, Aparicio T, Becouarn Y, Bedenne L, Michel P, Parc Y, Pocard M, Chibaudel B, Bouché O
Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)
Digestive and Liver Disease (IF = 3.287), 50(1), 15-19, 2018

Taieb J, Kourie HR, Emile JF, Le Malicot K, Balogoun R, Tabernero J, Mini E, Folprecht G, Van Laethem JL, Mulot C, Bouché O, Aparicio T, Michel P, Thaler J, Bridgewater J, Van Cutsem E, Perkins G, Lepage C, Salazar R, Laurent-Puig P
Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status
JAMA Oncology (IF = 20.871), 4(7), e173695, 2018

Bulsei J, Leroy S, Perotin JM, Mal H, Marquette CH, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Salaün M, Marceau A, Dukic S, Barbe C, Bonnaire M, Deslee G, Durand-Zaleski I
Cost-effectiveness of lung volume reduction coil treatment in patients with severe emphysema: results from the 2-year follow-up crossover REVOLENS study (REVOLENS-2 study)
Respiratory Research (IF = 3.751), 19(1), 84, 2018

Sargos P, Baumann BC, Eapen L, Christodouleas J, Bahl A, Murthy V, Efstathiou J, Fonteyne V, Ballas L, Zaghloul M, Roubaud G, Orré M, Larré S
Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy
Cancer Treatment Reviews (IF = 8.122), 70, 88-97, 2018

Rouanne M, Roumiguié M, Houédé N, Masson-Lecomte A, Colin P, Pignot G, Larré S, Xylinas E, Rouprêt M, Neuzillet Y
Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways
World Journal of Urology (IF = 2.981), 36(11), 1727-1740, 2018

Laclergerie F, Mouillet G, Frontczak A, Balssa L, Eschwege P, Saussine C, Larré S, Cormier L, Vuillemin AT, Kleinclauss F
Testicle-sparing surgery versus radical orchiectomy in the management of Leydig cell tumors: results from a multicenter study
World Journal of Urology (IF = 2.981), 36(3), 427-433, 2018

Rouprêt M, Neuzillet Y, Pignot G, Compérat E, Audenet F, Houédé N, Larré S, Masson-Lecomte A, Colin P, Brunelle S, Xylinas E, Roumiguié M, Méjean A
Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : tumeurs de la vessie
Progrès en Urologie (IF = 0.819), 28(12), S46-S78, 2018

Rouprêt M, Xylinas E, Colin P, Houédé N, Compérat E, Audenet F, Larré S, Masson-Lecomte A, Pignot G, Brunelle S, Roumiguié M, Neuzillet Y, Méjean A
Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : tumeurs de la voie excrétrice supérieure
Progrès en Urologie (IF = 0.819), 28(12), S32-S45, 2018

Reix B, Bernhard JC, Patard JJ, Bigot P, Villers A, Suer E, Vuong NS, Verhoest G, Alimi Q, Beauval JB, Benoit T, Nouhaud FX, Lenormand C, Hamidi N, Cai J, Eto M, Larré S, El Bakhri A, Ploussard G, Hung A, Koutlidis N, Schneider A, Carrouget J, Droupy S, Marchal S, Doerfler A, Seddik S, Matsugasumi T, Orsoni X, Descazeaud A, Pfister C, Bensalah K, Soulie M, Gill I, Flamand V
Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR
Progrès en Urologie (IF = 0.819), 28(3), 146-155, 2018

Pignot G, Houédé N, Roumiguié M, Audenet F, Brunelle S, Colin P, Compérat E, Larré S, Masson-Lecomte A, Neuzillet Y, Xylinas E, Méjean A, Rouprêt M
ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology
Progrès en Urologie (IF = 0.819), 28(12), 567-574, 2018

Slimano F, Netzer F, Borget I, Lemare F, Besse B
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapy
International Journal of Clinical Pharmacy (IF = 1.508), 40(5), 1265-1271, 2018

Mongaret C, Quillet P, Vo TH, Aubert L, Fourgeaud M, Michelet-Huot E, Bonnet M, Bedouch P, Slimano F, Gangloff SC, Drame M, Hettler D
Predictive factors for clinically significant pharmacist interventions at hospital admission
Medicine (IF = 2.028), 97(9), e9865, 2018

Hamel C, Tortolano L, Bermudez E, Desmaris R, Klein S, Slimano F, Lemare F
Computerized pediatric oncology prescriptions review by pharmacist: A descriptive analysis and associated risk factors
Pediatric Blood & Cancer (IF = 2.646), 65(4), 2018

Mulé S, Thiéfin G, Costentin C, Durot C, Rahmouni A, Luciani A, Hoeffel C
Advanced hepatocellular carcinoma: pretreatment contrast-enhanced CT texture parameters as predictive biomarkers of survival in patients treated with sorafenib
Radiology (IF = 7.469), 288(2), 445-455, 2018

Barrault F, Dramé M, Heurgue A, Piardi T, Bernard-Chabert B, Hoeffel C, Sommacale D, Thiéfin G
General practitioner density is not associated with survival in patients with hepatocellular carcinoma
Santé Publique (IF = 0.249), 30(5), 679-687, 2018

Cacoub P, Nahon P, Layese R, Blaise L, Desbois AC, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Capron D, Thiéfin G, Zucman D, Di Martino V, Bagnis CI, Ziol M, Sutton A, Letouze E, Roudot-Thoraval F, Audureau E
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients
American Heart Journal (IF = 4.171), 198, 4-17, 2018

Lebrun D, Floch T, Brunet A, Julien G, Romaru J, N'Guyen Y, Cousson J, Giltat A, Toubas D, Bani-Sadr F
Severe post-artesunate delayed onset anaemia responding to corticotherapy: a case report
Journal of Travel Medicine (IF = 1.800), 25(1), 2018

Dupont D, Huguenin A, Tisserand E, Reiter V, Morelon E, Badet L, Villena I, Wallon M, Toubas D
Donor Derived Candida stellimalicola in a Clinical Specimen: Preservation Fluid Contamination During Pancreas Procurement
Mycopathologia (IF = 1.476), 183(3), 573-577, 2018

Nevez G, Le Gal S, Noel N, Wynckel A, Huguenin A, Le Govic Y, Pougnet L, Virmaux M, Toubas D, Bajolet O
Investigation of nosocomial pneumocystis infections: usefulness of longitudinal screening of epidemic and post-epidemic pneumocystis genotypes
Journal of Hospital Infection (IF = 3.354), 99(3), 332-345, 2018

Bailly E, Anglicheau D, Blancho G, Gatault P, Vuiblet V, Chatelet V, Morelon E, Malvezzi P, Parissiadis A, Tourret J, Guidicelli G, Sayegh J, Mousson C, Grimbert P, Top I, Le Quintrec M, Purgus R, Westeel PF, Proust B, Chabot V, Lebranchu Y, Dehaut F, Büchler M
Prognostic Value of the Persistence of C1q-Binding Anti-HLA Antibodies in Acute Antibody-Mediated Rejection in Kidney Transplantation
Transplantation (IF = 3.960), 102(4), 688-698, 2018

Derruau S, Renard Y, Pron H, Taiar R, Abdi E, Polidori G, Lorimier S
Combining Magnetic Resonance Imaging (MRI) and Medical Infrared Thermography (MIT) in the pre- and peri-operating management of severe Hidradenitis Suppurativa (HS)
Photodiagnosis and Photodynamic Therapy (IF = 2.895), 23, 9-11, 2018